Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

The world’s first robotic transcatheter mitral valve replacements | Tiny pacemakers for infants | Building a CCTA program

News You Need to Know Today
The world’s first robotic transcatheter mitral valve replacements | Tiny pacemakers for infants | Building a CCTA program
Friday, March 7, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements

One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."

READ MORE >
Capstan Medical robotic transcatheter mitral valve replacement. Capstan Medical, a California-based medtech company focused on developing new structural heart disease treatments, announced the news, noting that its robotic-enabled technologies were used to complete two successful robotic TMVR procedures at Hospital Clínico Universidad Católica in Santiago, Chile.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements

Share on Twitter Share on Facebook Share on Linkedin
Capstan Medical robotic transcatheter mitral valve replacement. Capstan Medical, a California-based medtech company focused on developing new structural heart disease treatments, announced the news, noting that its robotic-enabled technologies were used to complete two successful robotic TMVR procedures at Hospital Clínico Universidad Católica in Santiago, Chile.
One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."
READ MORE >

‘A new alternative’: Tiny pacemakers for infants show early promise

A team of pediatric specialists worked closely with representative from Medtronic to develop the new pacemakers. Overall, the tiny devices—approximately one-quarter the size of a traditional pacemaker—were found to be both safe and effective. They are still under development.

READ MORE >
Chest X ray in AP projection of a neonate with an epicardial left ventricular bipolar pacing lead connected to a pediatric implantable pulse generator (IPG) in the left upper abdominal pocket. Image and caption courtesy of the American Heart Association and Circulation: Arrhythmia and Electrophysiology.
Share on Twitter Share on Facebook Share on Linkedin

‘A new alternative’: Tiny pacemakers for infants show early promise

Share on Twitter Share on Facebook Share on Linkedin
Chest X ray in AP projection of a neonate with an epicardial left ventricular bipolar pacing lead connected to a pediatric implantable pulse generator (IPG) in the left upper abdominal pocket. Image and caption courtesy of the American Heart Association and Circulation: Arrhythmia and Electrophysiology.
A team of pediatric specialists worked closely with representative from Medtronic to develop the new pacemakers. Overall, the tiny devices—approximately one-quarter the size of a traditional pacemaker—were found to be both safe and effective. They are still under development.
READ MORE >

Deadline extended: Nominate a young cardiology professional today

Nominees for the Cardiovascular Business Forty Under 40 Awards can now be submitted through Sunday, March 9.

READ MORE >
primary care provider clinician physician doctor
Share on Twitter Share on Facebook Share on Linkedin

Deadline extended: Nominate a young cardiology professional today

Share on Twitter Share on Facebook Share on Linkedin
primary care provider clinician physician doctor
Nominees for the Cardiovascular Business Forty Under 40 Awards can now be submitted through Sunday, March 9.
READ MORE >

Building a successful CCTA program: Physicians and healthcare executives to share advice

CCTA continues to grow more and more important in the day-to-day treatment of heart patients. Hospitals and health systems that fail to embrace the modality risk falling behind.

READ MORE >
Patient undergoes a CT scan with IV contrast at Wellstar Kennestone Hospital. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Building a successful CCTA program: Physicians and healthcare executives to share advice

Share on Twitter Share on Facebook Share on Linkedin
Patient undergoes a CT scan with IV contrast at Wellstar Kennestone Hospital. Photo by Dave Fornell
CCTA continues to grow more and more important in the day-to-day treatment of heart patients. Hospitals and health systems that fail to embrace the modality risk falling behind.
READ MORE >

Featured Articles

FDA approves design updates for Perceval Plus surgical aortic valve

The valve's sutureless, collapsible frame was built to simplify implantation and help patients recover faster following surgery. This updated version features laser-cut details and was shaped using a zero-pressure fixation process.

READ MORE >
Corcym has received U.S. Food and Drug Administration (FDA) approval for a new version of its Perceval Plus surgical aortic heart valve that includes the company’s advanced LANCELOT features.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves design updates for Perceval Plus surgical aortic valve

Share on Twitter Share on Facebook Share on Linkedin
Corcym has received U.S. Food and Drug Administration (FDA) approval for a new version of its Perceval Plus surgical aortic heart valve that includes the company’s advanced LANCELOT features.
The valve's sutureless, collapsible frame was built to simplify implantation and help patients recover faster following surgery. This updated version features laser-cut details and was shaped using a zero-pressure fixation process.
READ MORE >

Cardiologists are first in world to use new TAVR catheter from Boston Scientific

The new Self-Centering Guide Catheter was designed to help care teams with the retrograde crossing of the aortic valve during TAVR. Researchers evaluated the safety and effectiveness of the catheter, sharing their experience in JACC: Cardiovascular Interventions.

READ MORE >
self-centering guide catheter (SCGC) for TAVR from Boston Scientific
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists are first in world to use new TAVR catheter from Boston Scientific

Share on Twitter Share on Facebook Share on Linkedin
self-centering guide catheter (SCGC) for TAVR from Boston Scientific
The new Self-Centering Guide Catheter was designed to help care teams with the retrograde crossing of the aortic valve during TAVR. Researchers evaluated the safety and effectiveness of the catheter, sharing their experience in JACC: Cardiovascular Interventions.
READ MORE >

FDA approves first new clot-dissolving drug for ischemic stroke in decades

Tenecteplase is a tissue plasminogen activator given to patients through a single five-second intravenous bolus. It is only the second drug of its kind to gain FDA approval, and the first in many years.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first new clot-dissolving drug for ischemic stroke in decades

Share on Twitter Share on Facebook Share on Linkedin
Tenecteplase is a tissue plasminogen activator given to patients through a single five-second intravenous bolus. It is only the second drug of its kind to gain FDA approval, and the first in many years.
READ MORE >

In Case You Missed It

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.

READ MORE >
Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.
Share on Twitter Share on Facebook Share on Linkedin

Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology

Share on Twitter Share on Facebook Share on Linkedin
Video of James Min, MD, explaining the future of cardiac care using CT and AI plaque analysis to create a personalized and more accurate cardiac risk assessment, similar to a mammogram for the heart.
James Min, MD, Cleerly's founder and CEO, changed careers to address what he saw as a major unmet need in cardiology.
READ MORE >

Getinge ending production of cardiopulmonary surgical perfusion systems

The global medtech company is also looking to expand its organ transplant and ECMO portfolios.

READ MORE >
Getinge says it is ending production of its cardio-pulmonary surgical perfusion product in 2025, but plans to invest more in its Maquet Cardiosave ECMO system, which has continued market growth. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Getinge ending production of cardiopulmonary surgical perfusion systems

Share on Twitter Share on Facebook Share on Linkedin
Getinge says it is ending production of its cardio-pulmonary surgical perfusion product in 2025, but plans to invest more in its Maquet Cardiosave ECMO system, which has continued market growth. Photo by Dave Fornell
The global medtech company is also looking to expand its organ transplant and ECMO portfolios.
READ MORE >

FDA approves first rapid-acting insulin biosimilar for diabetes

Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes.

READ MORE >
Sugar Insulin
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first rapid-acting insulin biosimilar for diabetes

Share on Twitter Share on Facebook Share on Linkedin
Sugar Insulin
Sanofi's Merilog is a new biosimilar substitute for Novo Nordisk’s NovoLog. It can be used to treat adult and pediatric patients with type 1 and type 2 diabetes.
READ MORE >

In Other News

CEO of Amazon’s One Medical steps down

Trent Green served in the role since September 2023. He’s leaving to take the helm at a data analytics firm. 

READ MORE >
Amazon is acquiring One Medical in a $3.9 billion deal
Share on Twitter Share on Facebook Share on Linkedin

CEO of Amazon’s One Medical steps down

Share on Twitter Share on Facebook Share on Linkedin
Amazon is acquiring One Medical in a $3.9 billion deal
Trent Green served in the role since September 2023. He’s leaving to take the helm at a data analytics firm. 
READ MORE >

Radiology pushes for doc fix as government funding deadline looms

Momentum is building for the Medicare Patient Access and Practice Stabilization Act, the AMA notes, with 99 bipartisan co-sponsors in the House. 

READ MORE >
Medicare
Share on Twitter Share on Facebook Share on Linkedin

Radiology pushes for doc fix as government funding deadline looms

Share on Twitter Share on Facebook Share on Linkedin
Medicare
Momentum is building for the Medicare Patient Access and Practice Stabilization Act, the AMA notes, with 99 bipartisan co-sponsors in the House. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Top 10 most popular cardiology video interviews this past month
Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026
Early reactions to proposed TAVR changes | Cardiology still an AI leader | More than 11K bottles of blood pressure drug recalled
TV star's family awarded $13M in malpractice case | Helping patients with ‘broken hearts’ | Cardiac amyloidosis in the spotlight
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup